Status
Conditions
About
Myocardial fibrosis is the fundamental substrate for the development of heart failure.
Cardiovascular magnetic resonance (CMR) allows non-invasive assessment of myocardial fibrosis based on late gadolinium enhancement (LGE) and T1 mapping.
Patients: Prospective longitudinal observational multicenter study of consecutive patients with suspected or known non-ischemic cardiomyopathy.
Imaging: Non-invasive measures of myocardial fibrosis: native T1, extracellular volume fraction (ECV) and LGE.
Primary endpoints: all cause and cardiovascular mortality.
Secondary endpoints: arrhythmic composite and HF composite endpoints.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
Exclusion criteria
contraindications for cardiac magnetic resonance imaging due to MR unsafe devices or objects
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal